AMDL, Inc. Builds Pipeline

AMDL Inc. (ADL) announced its wholly-owned China subsidiary, Jade Pharmaceutical, will increase its product pipeline by increasing in-house research and in-licensing products from other companies. Currently, Jade has two products under consideration by the SFDA, a cancer diagnostic test kit and docetaxel injectables. More details...

Back to news